Fundz

Fundz Deep Dive

Everything you need to win VeraDermics — in one platform.

Who to reach, what to say, and why now on VeraDermics — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on VeraDermics — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Vera Dermics announced it raised $15 Million in an initial filing from an offering of $15 Million

PUBLIC · MANEMay 01, 2023•about 3 years ago

Amount Raised

$15 Million

New HavenHealthcareHealth Care

Company Information

Company

VeraDermics

Location

New Haven, Connecticut, United States

About

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care. We are on a mission to make long-ignored dermatology and aesthetics conditions simple, replacing false hope, confusion, and questionable results with solutions that people and providers can trust. Our lead investigational product has the potential to be the first non-hormonal oral therapeutic for hair regrowth in women and men. Pattern hair loss, also known as androgenetic alopecia, is the largest aesthetics condition worldwide, with no new approved prescription therapies in nearly 30 years.

Related People

Suggested for you
1 contact

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for VeraDermics's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching VeraDermics? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan